Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system (Q40190677)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 November 2006

Language	Label	Description	Also known as
English	Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system	scientific article published on 10 November 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

author name string

Sui-Wen Lin

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Ferng-Chun Ke

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Ping-Ping Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Ming-Ting Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Jiuan-Jiuan Hwang

6

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

language of work or name

0 references

publication date

10 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Experimental Cell Research

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

313

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

602-613

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Loss of ovarian function and the risk of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Ovarian cancer metastasis: integrating insights from disparate model organisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Plasminogen activation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

The urokinase-type plasminogen activator system in cancer metastasis: A review

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Matrix metalloproteinases: they're not just for matrix anymore!

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

The plasminogen activation system in tumor growth, invasion, and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Unexpected role of plasminogen activator inhibitor 1 in cell adhesion and detachment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Pleiotropic functions of plasminogen activator inhibitor-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Expression and activity of MMPS and their regulators in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

TGFbeta1 stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Role of MT-MMPs and MMP-2 in pancreatic cancer progression

2 references

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

MT1-MMP: a potent modifier of pericellular microenvironment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

The integrin-actin connection, an eternal love affair

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Integrin-linked kinase: a cancer therapeutic target unique among its ILK.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Cell-free 59 kDa immunoreactive integrin-linked kinase: a novel marker for ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Transforming Growth Factor-β1 Produced by Ovarian Cancer Cell Line HRA Stimulates Attachment and Invasion through an Up-regulation of Plasminogen Activator Inhibitor Type-1 in Human Peritoneal Mesothelial Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

TGF-?-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Transforming growth factor-beta1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

A Kunitz-type protease inhibitor, bikunin, inhibits ovarian cancer cell invasion by blocking the calcium-dependent transforming growth factor-beta 1 signaling cascade

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Cloning of an isoform of integrin-linked kinase (ILK) that is upregulated in HT-144 melanoma cells following TGF-beta1 stimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Pituitary adenylate cyclase-activating polypeptide acts synergistically with relaxin in modulating ovarian cell function in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Type-1 plasminogen-activator inhibitor -- conformational differences between latent, active, reactive-centre-cleaved and plasminogen-activator-complexed forms, as probed by proteolytic susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Involvement of furin-like proprotein convertases in the arterial response to injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Intracellular dynamics of Smad‐mediated TGFβ signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Genetic down-regulation of phosphoinositide 3-kinase by bikunin correlates with suppression of invasion and metastasis in human ovarian cancer HRA cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Integration of cell attachment, cytoskeletal localization, and signaling by integrin-linked kinase (ILK), CH-ILKBP, and the tumor suppressor PTEN.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

ILK mediates actin filament rearrangements and cell migration and invasion through PI3K/Akt/Rac1 signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

High tissue content of urokinase plasminogen activator (u-PA) is associated with high stromal expression of u-PA mRNA in poorly differentiated serous ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Urokinase and plasminogen activator-inhibitor (PAI-1) status in primary ovarian carcinomas and ovarian metastases compared to benign ovarian tumors as a function of histopathological parameters

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.11.003

7 January 2021

Identifiers

10.1016/J.YEXCR.2006.11.003

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40190677&oldid=1888525770"